SUMMA HEALTH SYSTEM has a total of 25 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, environmental technology and medical technology are IRR INC, VELCERA PHARMACEUTICALS INC and SUBLIMITY THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 3 | |
#6 | New Zealand | 2 | |
#7 | Mexico | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Miller Thomas M | 21 |
#2 | Jamison James M | 21 |
#3 | Neal Deborah R | 16 |
#4 | Mostardi Richard Albert | 10 |
#5 | Kovacik Mark William | 10 |
#6 | Mcguire Karen M | 10 |
#7 | Askew Michael John | 10 |
#8 | Larusso Nicholas F | 4 |
#9 | Masyuk Tetyana V | 4 |
#10 | Summers Jack L | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016069458A1 | Vitamin c and vitamin k compound for treating pancreatic cancer | |
US2015272924A1 | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing | |
MX2013000694A | Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease. | |
CN102480949A | Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant | |
CA2689717A1 | Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone | |
US2007043110A1 | Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins | |
US7091241B2 | Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined vitamins C and K3 | |
US5460970A | Separation of acetaldehyde-induced hemoglobin (Hb A1-AcH) |